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Abstract
Telemedicine use for patients with autoimmune rheumatic conditions during the pandemic mandates better characterization.
We conducted a telephonic survey on patients who consulted rheumatologists remotely to determine their attitudes toward
telemedicine. The study was conducted at Aga Khan University Hospital, a tertiary care hospital in Pakistan which is a lowermiddle-income country. Descriptive analyses were performed. Fifty patients visited tele-rheumatology clinic, 35 (70.0%) were
female with a mean (SD) age of 47.6 (18.1) years. Majority (27, 54.0%) learned about telemedicine from hospital website and
outpatient clinic desk or helpline. Lack of examination was the biggest concern with teleconsultation (18, 22.2%). Most
patients (38, 76.0%) agreed to continue teleconsultation beyond the pandemic. Telemedicine is preferable for providing rheumatology outpatient service during and after the pandemic.
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Introduction
Covid-19 pandemic resulted in a challenging situation globally. Lack of effective treatment, social boundary, and lockdown were the main preventive measures during the initial
pandemic period rendering telemedicine a safer option for
interaction between patients and clinicians (1).
Telemedicine (also known as teleconsultation interchangebly) uses 2-way telecommunication technology to
provide clinical healthcare through a variety of remote
methods. Initially, teleconsultation was primarily utilized to
manage and follow Covid-19 patients in the outpatient
setting (2). Nonetheless, the nature of the pandemic and the
increasing number of patients with chronic medical conditions in other specialties necessitated the use of teleconsultation services for all patients with such conditions (3,4).
Communicating with their physician on a live video call
can help patients with autoimmune diseases who are receiving immunosuppressant therapy to minimize the risk of
acquiring a new infection. Unfortunately, the provision of
remote clinical care or telemedicine for patients with autoimmune rheumatic conditions during the Covid-19 pandemic
has not been well-characterized. Therefore, we sought to
understand the attitude and perspective of patients suffering

from such chronic diseases who utilized the teleconsultation
facility during the pandemic.

Methodology
A cross-sectional telephonic survey was conducted in the rheumatology outpatients’ services of a tertiary care hospital (Aga
Khan University Hospital) after approval by the institutional
ethical review committee (ERC# 2020-5586-15348). All
patients who consulted a rheumatologist through teleconsultation services between June 2020 and November 2020 were
enrolled. Information on individual patient teleconsultation
was retrieved from the computerized outpatient medical
record. A telephonic interview was conducted with patients
who gave verbal consent. None of the patients refused
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participation in the survey, and they did not receive any ﬁnancial remuneration. An experienced qualitative researcher who
was not part of the rheumatology team providing clinical
service conducted all interviews in December 2020. The interview consisted of single and multiple-choice questions. Each
interview lasted for 15 to 20 min and was transcribed into a predesigned form. No recording of the interview was conducted.
Demographics, rheumatological diagnoses, and history of
Covid-19 illness were recorded. The questions were designed
to determine patients’ attitudes to teleconsultation and
in-person clinic visit, their concerns regarding teleconsultation, and the potential scope of such a remote healthcare
service in the future. The responses obtained were analyzed
by using Statistical Package for the Social Sciences version
22.0. Descriptive analyses were performed.

(28, 56.0%) used telemedicine service for a regular follow-up
visit to discuss the status of their disease. Baseline demographics of the study population ﬁndings are shown in
Table 1. Rheumatoid arthritis was the most common inﬂammatory condition during teleconsultation (10, 20.0%). Out of
50, 6 (12.0%) patients suffered from Covid-19. Nearly half of
the study population (23, 46.0%) were using prednisolone,
followed by hydroxychloroquine (14, 28.0%) and sulfasalazine (7, 14.0%). Four (8.0%) patients were receiving biological disease-modifying drugs. Thirteen (26.0%) patients
stopped taking conventional synthetic disease-modifying
anti-rheumatic drugs due to fear of having Covid-19 infection. Four (8.0%) patients discontinued hydroxychloroquine
due to non-availability of this drug during the pandemic.

Key Themes About Teleconsultations
Results
Baseline Demographics and Clinical Presentation
Overall, 50 patients contacted rheumatologists through teleconsultation service during the study period. Thirty-ﬁve
patients (70.0%) were female, with a mean (SD) age of
47.6 (18.1) years. The majority of the study population (33,
66.0%) had one teleconsultation appointment. Most patients
Table 1. Baseline Characteristics and Disease Presentation
Findings (N = 50).
Mean (SD) Age (years)
Gender
Female
Male
Residence
Urban
Rural
Educational background
Graduate
Higher secondary
Secondary level
Primary level
Rheumatological diagnosis
Non-inﬂammatory arthritis
Rheumatoid arthritis
Vasculitis
Systemic lupus erythematosus
Seronegative spondyloarthritis
Scleroderma
Rheumatic fever
Number of telehealth visits
One
Two
More than two
Reason for telehealth visits
Follow-up visit
New symptoms
Worsening of old symptoms
Suffered from SARS-CoV-2

47.6 (18.1)
35 (70.0%)
15 (30.0%)
45 (90.0%)
5 (10.0%)
27 (54.0%)
10 (20.0%)
7 (14.0%)
6 (12.0%)
26 (52.0%)
10 (20.0%)
5 (10.0%)
4 (8.0%)
3 (6.0%)
1 (2.0%)
1 (2.0%)
33 (66.0%)
9 (18.0%)
8 (16.0%)
28 (56.0%)
12 (24.0%)
10 (20.0%)
6 (12.0%)

The most common mode of learning about teleconsultation was
hospital website and outpatient clinic desk or helpline (27,
54.0%), followed by primary rheumatologist (9, 18.0%),
family and friends (8, 16.0%), social networking sites (5,
10.0%) and other patients (1, 2.0%). Twenty-eight (56.0%)
patients had no problem in seeing their rheumatologist in physical clinic when asked about the extent to which their usual
physical clinic visit was affected. Fifteen (30.0%) patients
thought about visiting an alternate facility if teleconsultation
was not an option to seek medical care. Approximately oneTable 2. Key Themes About Teleconsultations.
Common advices sought during rheumatology teleconsultation
Worsening of usual disease symptoms
Development of new symptoms
Modiﬁcation of treatment
Side effects related to treatment
Common concerns regarding
teleconsultation
Lack of physical examination performed by
doctor
Doctor not giving enough time during
teleconsultation
Unable to accurately present my complaints
to doctor
Hearing issues during teleconsultation
Doctor unable to understand my complaints
Problems with using phone or computer
Receiving wrong drug prescriptions
Lack of possibility of performing additional tests
Lack of access to equipment (computer, tablet,
phone)
Common reasons for continuing
teleconsultation beyond pandemic
Long waiting times for traditional in-person
clinic visit
Teleconsultations are more time convenient
Difﬁculty in walking
Fear of infections

36 (48.6%)
18 (24.3%)
12 (16.2%)
8 (10.8%)
18 (21.7%)
13 (15.7%)
12 (14.%)
10 (12.0%)
9 (10.8%)
7 (8.4%)
6 (7.2%)
4 (4.8%)
4 (4.8%)

34 (39.5%)
33 (38.4%)
11 (12.8%)
8 (9.3%)
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third (14, 28.0%) of the patients reported that they required
another person’s assistance to participate in teleconsultation.
Worsening of usual disease symptoms (36, 48.6%) was
the most common reason for seeking medical care through
teleconsultation during the lockdown period. Common concerns raised by teleconsultation participants are summarized
in Table 2. The most highlighted limitation was lack of physical examination (18, 21.7%). Majority felt that the best
aspect of an in-person clinic visit in comparison to teleconsultation was the chance of physical examination (43,
47.2%), followed by a direct talk with the care provider
(35, 38.5%), possibility of discussing test results (10,
10.9%), or undergoing additional testing (3, 3.3%).

Teleconsultation Beyond the Pandemic
Overall, 38 (76.0%) patients preferred continuing rheumatology teleconsultation beyond the pandemic, while 12 (24.0%)
patients showed a future preference for an in-person visit
only. Out of those who wanted to continue teleconsultaion
services beyond the pandemic, 22 (57.9%) patients felt that
a combination of teleconsultation and an in-person visit
would be a more appropriate option. Common reasons for
continuing telemedicine service are also mentioned in
Table 2. The most common reason for choosing teleconsultation over traditional in-person clinic visits was the long
waiting time in physical consultation clinic (34, 39.5%).

Limitations
To the best of our knowledge, this is the ﬁrst study from
Pakistan done in patients with autoimmune rheumatic disorders, to determine the perceptions and concerns of end-users
regarding telemedicine services. However, there are certain
limitations to this study. Firstly, the sample size is small; therefore, stratiﬁcation is not possible to ﬁnd out proper associations.
Secondly, the study is based on recall of the patients’ experiences, resulting in recall bias. Thirdly, the study has selection
bias since it only included patients who sought medical help
through telemedicine services and did not include patients
who waited for an in-person visit. Furthermore, most of the
patients in this study are from Urban area either due to high percentage of clinic patient population being urban since urban
areas offer better internet connectivity and technological assistance than the rural areas. Another reason for high percentage
of urban population is because of increased
telemedicine awareness among them due to higher literacy
rate as compared to remote rural areas of our country.
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of telemedicine services and wish to continue this service
once the pandemic is over. A higher proportion of females in
our study concurs with an increased prevalence of rheumatic
diseases among young women in our urban population (5). A
similar demographic pattern is seen in other studies done
around the world (6–9). Our study shows arthritis to be the
most common reason for teleconsultation. Gkrouzman et al.
also stated that the effectiveness of teleconsultation in rheumatology has mostly been seen in patients with inﬂammatory
arthritis, and data is scarce for the management of connective
tissue diseases through teleconsultation (10). Similar ﬁndings
have also been reported in other studies (7,8,11). In contrast,
research from the neighboring Indian population (9) showed
that almost half of the patients who availed telemedicine services had a diagnosis of SLE. Another study from Hong
Kong conducted in Lupus Nephritis patients showed a good
acceptance of teleconsultation (12). Our study also reported
that a quarter of patients had either deescalated or stopped
their treatment regimen during the pandemic citing fear of
catching Covid-19 infection. Research from India reported a
similar rate of patients who stopped taking regular medicines
due to their ﬁnancial constraints (9). A similar percentage of
patients altered their medications in a study from North
America without any speciﬁc reason (7).

Positive Factors for Patients
Teleconsultation for autoimmue rheumatic diseases is a
promising substitute to in-person clinical visits for
follow-up patients who have exacerbation of their usual
musculoskeltal complaints. Review of literature has
shown that teleconsultation follow-up visits were
common than the ﬁrst-ever consultation for musculoskeletal diseases (13). The majority of patients in our study
who sought medical advice through teleconsultation
belonged to follow-up category rather than initial patient
category and reported worsening of their usual symptoms.
This is likely due to an already established rapport
between doctor and patient. Follow-up teleconsultation
offers another beneﬁt by providing the patient and rheumatologist a chance to review their medications and this
may help in reducing the percentage of patients who had
stopped or de-escalated their medication due to fear of
infections. Hall et al. also demonstrated another positive
aspect of teleconsultation in their study (13), in which
patients believed that teleconsultation was less crowded
than the in-person clinic visit. Another study highlighted
convenience of time, avoiding long queues, and less
chances of catching infections as beneﬁts of teleconsultations (8).

Discussion and Recommendations
Generalizability of Results

Limitations for Patients

Our study is a ﬁrst from a lower-middle-income country
describing the attitude of rheumatology patients towards telemedicine. Generally, people have shown a good acceptance

Our research has emphasized particular concerns raised by
the participants concerning teleconsultation. The foremost
is lack of physical examination, followed by less time
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given by the rheumatologist, and difﬁculty in describing their
symptoms remotely and making the doctor understand.
These factors becomes a bigger limitation while teleconsulting a patient for new symptoms as that requires a much more
detailed clinical examination. McDougall et al. also questioned the accuracy of teleconsultation in diagnosing new
rheumatic conditions as compared to its application for
follow-up of an already established diagnosis (14). A study
from Poland also stated that the lack of possibility to
perform new tests like ultrasound examination and lack of
physical examination were the main concerns faced by
patients availing teleconsultation (8).

Likelihood and Rationale for Continuation
of Teleconsulatation
The World Health Organization recommends digital technologies like teleconsultation to meet the growing burden of
rheumatic diseases (15). Covid-19 pandemic affected the
delivery of rheumatology services and hence accelerated
the use of telemedicine services to cater a large number of
patients in both near and remote areas (10). Most of our
patients wanted to continue with telemedicine services
beyond the pandemic since it is a time-saving way of
seeking medical help as well as has less chance of catching
up an infection. They also showed a preference for having
a combination of both in-person clinic visits and teleconsultations when required.
Telemedicine services offer a valuable, well-accepted, and
practical method of providing rheumatological services during
and after the Covid-19 pandemic. However, our patient population lacks insight into its utility to address medical problems
remotely and without physical interaction. We strongly feel
that the feasibility and application of telemedicine in resourcelimited settings and low-middle-income countries must be
established to avail its potential to transform healthcare
across the globe.
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